Equity Overview
Price & Market Data
Price: $23.24
Daily Change: +$1.11 / 4.78%
Daily Range: $20.84 - $23.53
Market Cap: $75,194,016
Daily Volume: 3,564
Performance Metrics
1 Week: 7.35%
1 Month: 0.91%
3 Months: -26.98%
6 Months: 8.55%
1 Year: 42.58%
YTD: -25.03%
Company Details
Employees: 4
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company offers ZELSUVMI for the treatment of molluscum contagiosum in adults and children 1 year of age and older. It also provides NITRICIL, a proprietary nitric oxide-based technology platform. The company was formerly known as Channel Therapeutics Corporation and changed its name to Pelthos Therapeutics Inc. in July 2025. Pelthos Therapeutics Inc. was founded in 2002 and is based in Durham, North Carolina.